CS logo
small CS logo
IASO General Hospital of Athens, 1st Dep of Medical Oncology

Athens, Greece
Maternity hospital in Marousi
Leof. Kifisias 37-39, Marousi 151 23

About IASO General Hospital of Athens, 1st Dep of Medical Oncology


"Το ΙΑΣΩ, από το 1996 που ιδρύθηκε στην Αθήνα, αποτελεί τη μεγαλύτερη Μαιευτική και Γυναικολογική κλινική στην Ευρώπη και το μεγαλύτερο ιδιωτικό νοσοκομείο στην Ελλάδα. Το ΙΑΣΩ με περισσότερους από 10.000 τοκετούς ετησίως και χιλιάδες γυναίκες να έχουν εμπιστευτεί τις υψηλού επιπέδου υπηρεσίες του, αποτελεί διαχρονικά την πρώτη επιλογή για τους γονείς που φέρνουν στον κόσμο το παιδί τους. Το ΙΑΣΩ διαθέτει ιατροτεχνολογικό εξοπλισμό τεχνολογίας αιχμής ο οποίος διασφαλίζει την παροχή υπηρεσιών υγείας υψηλού επιπέδου, παρακολουθώντας τις συνεχείς τεχνολογικές εξελίξεις και εισάγοντας καινοτόμες μεθόδους. Με αυστηρή προσήλωση στις διαδικασίες διασφάλισης ποιότητας το διοικητικό προσωπικό είναι επικεντρωμένο στην άρτια εξυπηρέτηση των ασθενών."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hellenic Oncology Research Group
53
Hoffmann-La Roche
10
Celgene
3
University Hospital of Crete
3
Elpen Pharmaceutical Co. Inc.
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Iaso Maternity Hospital, Athens, Greece
1
OSI Pharmaceuticals
1
Vaxon Biotech
1
Total Rows: 9

Clinical Trials at IASO General Hospital of Athens, 1st Dep of Medical Oncology


During the past decade, IASO General Hospital of Athens, 1st Dep of Medical Oncology conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44442222111100112200002211113300Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients
2001-06-01
2013-08-01
Completed
658
Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma
2006-06-01
2011-07-01
Completed
31
Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer
2002-05-01
2007-11-01
Completed
272
Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
2004-07-01
2008-05-01
Completed
135
Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
2004-08-01
2007-10-01
Completed
478
Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer
2002-04-01
2009-01-01
Completed
144
Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)
2006-03-01
2009-02-01
Terminated
38

Rows per page:

1–74 of 74

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "IASO General Hospital of Athens, 1st Dep of Medical Oncology" #1 sponsor was "Hellenic Oncology Research Group" with 53 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Celgene" with 3 trials sponsored, "University Hospital of Crete" with 3 trials sponsored and "Elpen Pharmaceutical Co. Inc." with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "IASO General Hospital of Athens, 1st Dep of Medical Oncology" #1 collaborator was "University Hospital of Crete" with 37 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHellenic OncologyResearch Group: 53Hellenic OncologyResearch Group: 53Hoffmann-La Roche: 10Hoffmann-La Roche: 10Celgene: 3Celgene: 3University Hospital of Crete: 3University Hospital of Crete: 3Elpen Pharmaceutical Co. Inc.: 1Elpen Pharmaceutical Co. Inc.: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Iaso Maternity Hospital,Athens, Greece: 1Iaso Maternity Hospital,Athens, Greece: 1OSI Pharmaceuticals: 1OSI Pharmaceuticals: 1Vaxon Biotech: 1Vaxon Biotech: 1

Created with Highcharts 11.1.0Top CollaboratorsUniversity Hospital of Crete: 37University Hospital of Crete: 37BeiGene: 1BeiGene: 1Borstkanker OnderzoekGroep: 1Borstkanker OnderzoekGroep: 1Breast International Group: 1Breast International Group: 1Cancer Trials Ireland: 1Cancer Trials Ireland: 1Foundation Medicine, Inc.: 1Foundation Medicine, Inc.: 1G.Gennimatas GeneralHospital: 1G.Gennimatas GeneralHospital: 1Harokopio University: 1Harokopio University: 1Hellenic CooperativeOncology Group: 1Hellenic CooperativeOncology Group: 1Hellenic OncologyResearch Group: 1Hellenic OncologyResearch Group: 1

Clinical Trials Conditions at IASO General Hospital of Athens, 1st Dep of Medical Oncology


According to Clinical.Site data, the most researched conditions in "IASO General Hospital of Athens, 1st Dep of Medical Oncology" are "Breast Cancer" (20 trials), "Non Small Cell Lung Cancer" (13 trials), "Colorectal Cancer" (4 trials), "Metastatic Breast Cancer" (4 trials) and "Non-small-cell Lung Cancer" (4 trials). Many other conditions were trialed in "IASO General Hospital of Athens, 1st Dep of Medical Oncology" in a lesser frequency.

Clinical Trials Intervention Types at IASO General Hospital of Athens, 1st Dep of Medical Oncology


Most popular intervention types in "IASO General Hospital of Athens, 1st Dep of Medical Oncology" are "Drug" (63 trials), "Other" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (20 trials), "Bevacizumab" (15 trials), "Gemcitabine" (13 trials), "Carboplatin" (10 trials) and "Vinorelbine" (9 trials). Other intervention names were less common.

Clinical Trials Genders at IASO General Hospital of Athens, 1st Dep of Medical Oncology


The vast majority of trials in "IASO General Hospital of Athens, 1st Dep of Medical Oncology" are 47 trials for "All" genders, 24 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at IASO General Hospital of Athens, 1st Dep of Medical Oncology


Currently, there are NaN active trials in "IASO General Hospital of Athens, 1st Dep of Medical Oncology". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in IASO General Hospital of Athens, 1st Dep of Medical Oncology, undefined suspended trials, and 21 terminated clinical trials to date.
Out of the total trials that were conducted in IASO General Hospital of Athens, 1st Dep of Medical Oncology, 8 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 39Phase 2: 39Phase 3: 22Phase 3: 22Phase 1: 8Phase 1: 8Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 43Completed: 43Terminated: 21Terminated: 21Active, not recruiting: 5Active, not recruiting: 5Unknown status: 3Unknown status: 3Withdrawn: 2Withdrawn: 2

Departments of IASO General Hospital of Athens, 1st Dep of Medical Oncology


IASO General Hospital of Athens, 1st Dep of Medical Oncology has several departments that took part in Clinical trials: "ARETAIEION UNIVERSITY HOSPITAL; oncology unit" - 2 trials
Departments List
Total Rows: 1